|

Anxiety Clinical Trials in Connecticut

15 recruiting studies across 7 cities

All Trials in Connecticut

Phase
Trial Phase Location
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)Phase 2Cromwell
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety DisorderPhase 2Cromwell
External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy—Darien
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety DisorderPhase 2Farmington
Easing Scan Anxiety in Pediatric Oncology Caregivers Through Meditation-based ProgramsN/AHartford
Aerobic Exercise and Obsessive-Compulsive Disorder SymptomsN/ANew Haven
Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of LifeN/ANew Haven
Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCDPhase 1/2New Haven
Efficacy of Valbenazine for the Treatment of Trichotillomania in AdultsPhase 2New Haven
Music for Pain and DementiaN/ANew Haven
Open-Label Psilocybin Study in Transdiagnostic PopulationPhase 1New Haven
Parent-Based Treatment for Adolescent AnxietyN/ANew Haven
Transcranial Direct Current Stimulation and Extinction in Obsessive Compulsive DisorderN/ANew Haven
Healing Hearts: A Mindfulness App for Parents Navigating Divorce or SeparationN/AStamford
Cannabidiol Effects on Learning and AnxietyEarly 1Storrs

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.